ConductScience.org, home

Paper24658779

Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole.

Ho TC and 4 others. Graefes Arch Clin Exp Ophthalmol, 2014. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole. Papers, record 24658779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24658779

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole.
PubMed
Journal
Graefes Arch Clin Exp Ophthalmol
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2021-10-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ho TCTzyy-Chang
2Yang CMChung-May
3Huang JSJen-Shang
4Yang CHChang-Hao
5Chen MSMuh-Shy

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Basement MembraneMajor topic
Retinal PerforationsMajor topic
VitrectomyMajor topic
Aged
Aged, 80 and over
Ependymoglial Cells
Female
Fovea Centralis
Humans
Male
Middle Aged
Retrospective Studies
Tomography, Optical Coherence
Visual Acuity

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121051731Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.Invest Ophthalmol Vis Sci2011https://conductscience.org/library/papers/21051731PubMed
210926987Internal limiting membrane removal in the management of full-thickness macular holes.Am J Ophthalmol2000https://conductscience.org/library/papers/10926987PubMed
323095727Visual outcome correlates with inner macular volume in eyes with surgically closed macular hole.Retina2012https://conductscience.org/library/papers/23095727PubMed
422929321Controversies regarding internal limiting membrane peeling in idiopathic epiretinal membrane and macular hole.Retina2012https://conductscience.org/library/papers/22929321PubMed
516877079Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study.Ophthalmology2006https://conductscience.org/library/papers/16877079PubMed
623471893Tomographic features of macula after successful macular hole surgery.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23471893PubMed
718806295Microplasmin: ex vivo characterization of its activity in porcine vitreous.Invest Ophthalmol Vis Sci2009https://conductscience.org/library/papers/18806295PubMed
816949459NFL appearance after peeling.Ophthalmology2006https://conductscience.org/library/papers/16949459PubMed
914704923Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green.Curr Eye Res2003https://conductscience.org/library/papers/14704923PubMed
1022867977Asymmetric elongation of foveal tissue after macular hole surgery and its impact on metamorphopsia.Ophthalmology2012https://conductscience.org/library/papers/22867977PubMed
1123579603Double peeling during vitrectomy for macular pucker: the Charles L. Schepens Lecture.JAMA Ophthalmol2013https://conductscience.org/library/papers/23579603PubMed
1216123432Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.Invest Ophthalmol Vis Sci2005https://conductscience.org/library/papers/16123432PubMed
1314744909Posterior vitreous detachment induced by microplasmin.Invest Ophthalmol Vis Sci2004https://conductscience.org/library/papers/14744909PubMed
1416095706Relationship of dissociated optic nerve fiber layer appearance to internal limiting membrane peeling.Ophthalmology2005https://conductscience.org/library/papers/16095706PubMed
1516809385Relationship between macular hole size and the potential benefit of internal limiting membrane peeling.Br J Ophthalmol2006https://conductscience.org/library/papers/16809385PubMed
1622374159Foveola nonpeeling technique in internal limiting membrane peeling of myopic foveoschisis surgery.Retina2012https://conductscience.org/library/papers/22374159PubMed
1723033391Assessment of retinal morphology with spectral and time domain OCT in the phase III trials of enzymatic vitreolysis.Invest Ophthalmol Vis Sci2012https://conductscience.org/library/papers/23033391PubMed
181485013Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade.Retina1992https://conductscience.org/library/papers/1485013PubMed
1921887098Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.Clin Ophthalmol2011https://conductscience.org/library/papers/21887098PubMed
2011133873Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery.Invest Ophthalmol Vis Sci2001https://conductscience.org/library/papers/11133873PubMed

See all 34 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
40595014A delphi consensus study for treatment of full-thickness macular hole in Taiwan.Sci Rep2025https://conductscience.org/library/papers/40595014PubMed
40323482Classification and management of myopic traction maculopathy: a vitrectomy-based consensus from taiwanese experts.Int Ophthalmol2025https://conductscience.org/library/papers/40323482PubMed
39582495Fovea-Sparing Internal Limiting Membrane (ILM) Peeling and ILM Plug: A Novel Approach for Managing Optic Disc Pit Maculopathy.Clin Ophthalmol2024https://conductscience.org/library/papers/39582495PubMed
37004698Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study.Ophthalmol Ther2023https://conductscience.org/library/papers/37004698PubMed
36872711Papillomacular bundle sparing versus conventional internal limiting membrane peeling for idiopathic macular hole ≤400 μm.Indian J Ophthalmol2023https://conductscience.org/library/papers/36872711PubMed
36249443Internal Limiting Membrane Peeling and Gas Tamponade For Full-Thickness Macular Holes of Different Etiology - Is It Still Relevant?Clin Ophthalmol2022https://conductscience.org/library/papers/36249443PubMed
35813123Internal limiting membrane peeling in macular hole surgery.Ger Med Sci2022https://conductscience.org/library/papers/35813123PubMed
35549885Vitrectomy with internal limiting membrane peeling and gas tamponade for myopic foveoschisis.BMC Ophthalmol2022https://conductscience.org/library/papers/35549885PubMed
35418741Spotlight on the Internal Limiting Membrane Technique for Macular Holes: Current Perspectives.Clin Ophthalmol2022https://conductscience.org/library/papers/35418741PubMed
35268365Outcomes of Vitrectomy with Fovea-Sparing and Inverted ILM Flap Technique for Myopic Foveoschisis.J Clin Med2022https://conductscience.org/library/papers/35268365PubMed
34917414Factors Associated with Anatomic Failure and Hole Reopening after Macular Hole Surgery.J Ophthalmol2021https://conductscience.org/library/papers/34917414PubMed
33976679Foveal-Sparing ILM Peeling in a Case with Vitreomacular Traction and Foveal Detachment.Case Rep Ophthalmol2021https://conductscience.org/library/papers/33976679PubMed
33936809Isolated Central Epiretinal Membrane: A Rare Complication of Fovea-Sparing Internal Limiting Membrane Peeling Technique.J Ophthalmol2021https://conductscience.org/library/papers/33936809PubMed
31690760Reconstructing Foveola by Foveolar Internal Limiting Membrane Non-Peeling and Tissue Repositioning for Lamellar Hole-Related Epiretinal Proliferation.Sci Rep2019https://conductscience.org/library/papers/31690760PubMed
29850211A Review of Surgical Outcomes and Advances for Macular Holes.J Ophthalmol2018https://conductscience.org/library/papers/29850211PubMed
29570581INTRAVITREAL GAS INJECTION WITH LASER PHOTOCOAGULATION FOR HIGHLY MYOPIC FOVEOSCHISIS: Technique and Outcome.Retina2019https://conductscience.org/library/papers/29570581PubMed
28630788Evaluation of Ganglion Cell-Inner Plexiform Layer Thickness after Vitreoretinal Surgery with Internal Limiting Membrane Peeling in Cases with Idiopathic Macular Hole.Turk J Ophthalmol2017https://conductscience.org/library/papers/28630788PubMed
27756275Fovea sparing internal limiting membrane peeling using multiple parafoveal curvilinear peels for myopic foveoschisis: technique and outcome.BMC Ophthalmol2016https://conductscience.org/library/papers/27756275PubMed
26834454Optimal management of idiopathic macular holes.Clin Ophthalmol2016https://conductscience.org/library/papers/26834454PubMed
26425351Complications of Macular Peeling.J Ophthalmol2015https://conductscience.org/library/papers/26425351PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24658779

GET https://conductscience.org/api/papers/v1/24658779/references?page=2